Bronchopulmonary Dysplasia in Preterm Infants: Pathophysiology and Management Strategies

By Carl T. D’Angio   William M. Maniscalco  

Pediatric Drugs, Vol. 6, Iss. 5, 2004-01 ,pp. : 303-330

Adis International

Access to resources Recommend Favorite

Management of Bronchopulmonary Dysplasia in Infants: Guidelines for Corticosteroid Use

By Grier David G.   Halliday Henry L.  

Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. : 15-29

Adis International

Access to resources Recommend Favorite

Therapy for bronchopulmonary dysplasia in premature infants focuses on reducing the effects of oxygen toxicity and mechanical ventilation

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 7, 2005-07 ,pp. : 11-14

Adis International

Access to resources Recommend Favorite

Optimal Vitamin D Status for the Prevention and Treatment of Osteoporosis

By Holick Michael F.  

Drugs & Aging, Vol. 24, Iss. 12, 2007-01 ,pp. : 1017-1029

Adis International

Access to resources Recommend Favorite

Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3816-3826

Bentham Science Publishers

Access to resources Recommend Favorite